Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

The ability to compare the volumes of patients’ brain structures to brain structure volumes of healthy controls is a powerful tool to help physicians assess possible existence of neurodegeneration or the progression of a neurodegenerative disorder.

To adjust for any variation in brain size, sex difference, and inter-individual head-size in a population, brain structure volumes are normalized (or scaled) to a common measurement.

Cortechs.ai’ quantitative imaging software uses Intracranial Volume (ICV) to normalize an individual’s brain structure volumes, and automatically calculates it during the post-processing of brain MRIs for volumetric analysis. This consistent measure gives clinicians additional context of their patient’s brain structure volumes, regardless of head size.

ICV, also known as TIV (Total Intracranial Volume), is the volume of the cranial cavity as taken from a 3D T1 MRI, as outlined by the supratentorial dura matter, or cerebral contour when dura is not clearly detectable.

Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products
Example of segmentation with intracranial mask from T1-weighted image. Image credit: Malone, I.B. et al. (2015). Accurate Automatic Estimation of Total Intracranial Volume: A Nuisance Variable with Less Nuisance. NeuroImage 104 (366-372).

ICV is a very consistent measure across the lifespan of a patient, making it a reliable tool for correction of head size variation across individuals. This correction is especially helpful when assessing neurodegenerative conditions.

For example, Patient A and Patient B both have thalamic volumes that are consistent with the average for their age and sex-matched population. Patient A is 5’6” tall, with an average head circumference, while Patient B is 6’2” tall with an above average head circumference. If the thalamic volumes could be interpreted without correcting for ICV, both patients would yield a normal result. However, once the patient’s thalamic volumes are normalized to their individual ICV, it could become apparent that Patient B’s thalamic volume is lower than expected for their age and gender.

NeuroQuant reports provide brain structure volumes (relevant to the report), % ICV and normative percentiles. NeuroQuant automatically calculates the ICV to accurately compare an individual’s brain structure volumes to Cortechs.ai’ age and sex-matched normative reference data. The ICV normalization and reference comparison on NeuroQuant reports provide physicians with a framework to better understand brain structure volumes when assessing patients.

Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

Need more information about ICV or Cortechs.ai quantitative image products? Contact us.

 

More Resources

09/18/2026

What a Head CT Can and Can’t Tell You About a Concussion

For Concussion Awareness Day, learn how quantitative CT analysis can help measure subtle structural changes and support follow-up after traumatic brain injury.

09/09/2026

Prostate Cancer Awareness Month: Finding the Cancer That Matters

How quantitative MRI can bring greater clarity to decisions across the prostate cancer journey.

09/01/2026

Quantifying What Matters: Advancing Alzheimer’s Imaging with NeuroQuant®

Explore how quantitative imaging is transforming Alzheimer’s care, from structural volumetrics and amyloid PET to treatment monitoring with NeuroQuant®.

08/19/2026

Brain Metastases Imaging Insights from SNO/ASCO 2026

Explore key insights from SNO/ASCO 2026 on brain metastases imaging, including lesion tracking, volumetric analysis, SRS workflows, and automated segmentation.

08/18/2026

Cortechs.ai Announces FDA Clearance for NeuroQuant® PET: Advancing Molecular Imaging for Cognitive Impairment

NeuroQuant® PET receives FDA 510(k) clearance, advancing quantitative PET imaging for cognitive impairment.

08/04/2026

Cortechs.ai Expands European CE Marking Across AI Imaging Platform, Accelerating Global Growth

Cortechs.ai expands EU CE Marking for the latest NeuroQuant®, NeuroQuant® Brain Tumor, and OnQ™ Prostate, advancing global AI imaging innovation
Scroll to Top